JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BERKOWITZ, B. A.
Right arrow Articles by WAY, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BERKOWITZ, B. A.
Right arrow Articles by WAY, E. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 177, Issue 3, 500-508, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


ANALGESIC ACTIVITY AND CENTRAL NERVOUS SYSTEM DISTRIBUTION OF THE OPTICAL ISOMERS OF PENTAZOCINE IN THE RAT

BARRY A. BERKOWITZ 1 and E. LEONG WAY 1

1 Department of Pharmacology, University of California Medical Center, San Francisco, California

Onset, intensity and duration of analgesia produced by the dl-, d-and l-isomers of pentazocine were measured by the blockade of the pain response elicited by i.a. bradykinin administration. Most of the analgetic activity of pentazocine was found to reside in the l-isomer; the d-isomer was weakly analgetic at 15 mg/kg. Peak analgesia appeared to correlate reasonably well with brain and plasma levels of pentazocine, estimated by a spectrophotofluorometric procedure with a sensitivity 0.1 µg of drug per g of brain and 0.04 µg/ml of plasma. After a 15 mg/kg dose s.c., central nervous system and plasma levels of all three pentazocine isomers reached maximal values within 30 minutes. Levels of the d-isomer in eight brain regions (cortex, cerebellum, medulla-pons, midbrain, hypothalamus, hippocampus, striatum and cord) tended to be slightly higher and to fall more rapidly than those of the l-and the dl-isomers. Early levels of all three isomers were found to be highest in the cortex or hypothalamus and lowest in the cord but the differences between the two areas were generally less than 20%. Differences in the regional central nervous system distribution of the optical isomers of pentazocine failed to account for their differences in pharmacologic activity.

Submitted on September 17, 1970
Accepted on February 22, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.